Introduction
Diabetes mellitus (DM), an important public health problem, is a chronic disease with high morbidity and mortality among patients, which impair their health and quality of life. 1 Diabetic nephropathy (DN) is one of the most common microvascular complications of diabetes; and it can lead to end-stage renal disease. 2 DN includes Type-1 diabetic nephropathy (T1DN), due to Type-1 diabetes mellitus, and Type-2 diabetic nephropathy (T2DN) due to Type-2 diabetes mellitus. 3, 4 Some investigations suggest that genetic factors might act with a key role in the susceptibility of DM developing into DN.
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Angiotensinogen, diabetes mellitus, diabetic nephropathy, gene polymorphisms, meta-analysis, racial differences studies at present; however, the available evidence reported to date is weak, due to a sparseness of data or disagreements among studies. We performed this meta-analysis to investigate the relationship between the AGT A1166C gene polymorphism and the susceptibility for DM developing into DN.
Materials and methods

Search strategy
Relevant studies were screened from the search engines of PubMed and Cochrane Library on 1 August 2014. We used '(angiotensinogen OR AGT) AND (diabetic nephropathy)' in PubMed and the Cochrane Library to complete the search. We also extended the search spectrum to 'related articles' and the bibliographies of all retrieved studies. If multiple publications of the same data from the same study group occurred, we only recruited the later paper for analysis.
Inclusion criteria
• • A case-control study;
• • The outcome had to be DN; and
• • There had to be at least two comparison groups (DN group versus DM group).
Exclusion criteria
• • Review articles, editorials and case reports;
• • Articles that did not provide the detailed genotype data of A1166C; • • Investigations of the association of other genes with DN; • • Investigations of the role of drugs to diseases; and • • Multiple publications of the same data from the same study group.
Data extraction and synthesis
The following information was extracted from each study, independently, by two investigators: First author's surname, year of publication, ethnicity of study population, the number of cases and controls for the A1166C genotype. Frequencies of the C allele were calculated for the case group and control group, from the corresponding genotype distribution. The results were compared and disagreements were resolved by discussion.
Statistical analysis
Available data was entered into the Cochrane Review Manager (RevMan, version 5) and analyzed. The pooled statistic was counted using the fixed effects model, but a random effects model was conducted when the p value of the heterogeneity test was < 0.1. Results were expressed with odds ratios (OR) for dichotomous data, and 95% CI were also calculated; p < 0.05 was required for the overall OR to be deemed statistically significant. I 2 was used to test the heterogeneity between the included studies. We classified the investigations into studies for Asians and for Caucasians, because genotype frequencies and prevalence of DN were different among ethnic groups. We used the Begg adjusted rank correlation test 6 and the Egger regression asymmetry test 7 to explore publication bias p < 0.1 was considered significant), when the sample number was more than five.
Results
Study characteristics
The search yielded 162 references: 162 from PubMed and 0 from the Cochrane Library. According to the inclusion and exclusion criteria, nine articles [8] [9] [10] [11] [12] [13] [14] [15] [16] were identified for the analysis of the between AGT A1166C gene polymorphism and the susceptibility of DM developing into DN, in our review ( Table 1 ).
Association of the AGT A1166C gene polymorphism with the risk of DM patients developing into DN
In this meta-analysis, the AGT CC genotype was associated with the susceptibility of DM developing into DN in the overall population, but the C allele and AA genotype were not (CC genotype: OR = 1.42; 95% CI 0.97-2.08; p = 0.07 and C allele: OR = 1.26; 95% CI 0.96-1.65; p = 0.10; and AA genotype: OR = 0.81; 95% CI 0.56-1.18, p = 0.28; with Figure 1 for the C allele, Figure 2 for the CC genotype and Figure 3 for the AA genotype; and Table 2 ). In the meta-analysis according to ethnicity, we found that the AGT C allele and CC genotype were associated with the risk of DM developing into DN in the Asian population, but the AA genotype was not (Table 2) ; however, the AGT A1166C gene polymorphisms were not associated with the susceptibility of DM developing into DN in the Caucasian population ( Table 2) .
A sensitivity analysis for the relationship between the AGT A1166C gene polymorphism and the susceptibility of DM developing into DN was also performed according to the types of DM. In the sensitivity analysis, the AGT A1166C gene polymorphisms were not associated with the susceptibility of T1DM developing into T1DN in the overall population (Table 2) ; however, the AGT CC genotype was associated with the susceptibility of T2DM developing into T2DN in the overall population, while the C allele and AA genotype were not ( Table 2 ).
Evaluation of publication bias
No significant publication bias was shown in this metaanalysis (Begg p = 1.000, Egger p = 0.826; Figure 4 has the Begg test results).
discussion
We included nine studies into this meta-analysis and we found that the AGT CC genotype was associated with the susceptibility of DM developing into DN in the overall population, but the C allele and AA genotype were not. Furthermore, the AGT C allele and CC genotype were associated with the risk of DM developing into DN in the Asian population, but the AA genotype was not; however, the AGT A1166C gene polymorphisms were not associated with the susceptibility of DM developing into DN in the Caucasian population. There was no publication bias in this meta-analysis and the results for overall populations might be robust to some extent; however, the number of included studies for the Asian and Caucasian populations were small, so more studies in these populations should be performed in the future.
In the sensitivity analysis, the relationship between the AGT A1166C gene polymorphism and the susceptibility of DM developing into DN was also performed according to the types of DM. We found that the AGT A1166C gene polymorphism was not associated with the susceptibility of T1DM developing into T1DN, in the overall population; however, the AGT CC genotype was associated with the susceptibility of T2DM developing into T2DN in the overall population, but the C allele and AA genotype were not.
In our investigation, we found that the AGT CC genotype was associated with the susceptibility of DM to develop into DN in the overall population, and the AGT C allele and CC genotype were associated with the risk of DM developing into DN in the Asian population. Furthermore, the AGT CC genotype was associated with the susceptibility of T2DM developing into T2DN in overall population; however, these findings should be regarded cautiously, because many other ingredients, such as the heterogeneity of the enrolled cases, limited statistical power, variable study designs and different interventions, were closely related to affecting the results. Furthermore, whether the AGT A1166C polymorphism is just linked with other discrete loci involved in the susceptibility of DM developing into DN is not clear at the moment.
conclusions
In conclusion, the results in our study support that the AGT CC genotype was associated with the susceptibility of DM developing into DN in the overall population, and the AGT Caucas  T1DM  9  29  35  73  47  146  7  25  47  79  39  158  Tomino, 1999  Asian  T2DM --128 745  ----61 407  --Van Ittersum, 2000 Caucas  T1DM 21  88  91 200  130  400  10  53  37 100  73  200  Fradin, 2002  Caucas  T2DM 12  31  74 117  55  234  5  52  61 118  62  236  Prasad, 2006  Asian  T2DM  5  22 169 196  32  392  2  29 194 225  33  450  Möllsten, 2008  Caucas  T1DM  1  20  52  73  22  146  5  56 136 197  66 C allele and CC genotype were associated with the risk of DM developing into DN in the Asian population. Furthermore, the AGT CC genotype was associated with the susceptibility of T2DM to develop into T2DN in the overall population; however, more case-control association investigations on larger, stratified populations are required to further clarify the role of this AGT A1166C gene polymorphism in the susceptibility of DM developing into DN. 
